Federal Cannabis Legalization

Federal Cannabis Legalization: Where Things Stand in 2025

ZenWeedGuide Editorial Team  |  May 11, 2026

Updated 2025  |  By the ZenWeedGuide Editorial Team  |  10 min read

Background: How the US Got Here

The United States has had a complicated, often contradictory relationship with cannabis for over a century. What began as widespread, largely unregulated use in the early 1900s was curtailed by the Marihuana Tax Act of 1937, effectively criminalizing the plant at the federal level. Then, in 1970, the Controlled Substances Act (CSA) under President Nixon placed cannabis in Schedule I — alongside heroin — classifying it as a drug with "no accepted medical use and a high potential for abuse." That classification, controversial from the start, has remained unchanged for more than five decades.

The war on drugs that followed devastated communities across the country, disproportionately impacting Black and Latino Americans. Studies consistently show that despite similar usage rates across racial groups, Black Americans were nearly four times more likely to be arrested for cannabis possession than white Americans, according to ACLU data. This racial disparity has become a central argument in the modern legalization debate, with advocacy groups insisting that any federal reform must include meaningful expungement of prior convictions and social equity provisions.

The modern reform movement gained real momentum in 1996 when California passed Proposition 215, the nation's first statewide medical cannabis law. Colorado and Washington followed in 2012, becoming the first states to legalize recreational adult use — directly defying federal law. The Obama administration responded with the Cole Memorandum in 2013, instructing federal prosecutors to deprioritize enforcement in states with robust regulatory frameworks. That memo was rescinded by Attorney General Jeff Sessions in 2018, triggering alarm across the industry before the DOJ quietly backed away from aggressive enforcement again.

Today, more than two dozen states have full adult-use programs, and nearly every state has some form of cannabis law on the books. Yet the federal government's hands-off posture has never translated into legal clarity. Businesses can't access standard banking. Researchers face extraordinary barriers to studying the plant. And consumers crossing state lines with legally purchased cannabis technically commit a federal crime. The pressure to resolve this contradiction has never been greater — but federal action remains elusive.

Understanding the legislative landscape requires familiarity with several key bills, agencies, and legal concepts. Our explainers section covers the nuances of scheduling, the difference between decriminalization and legalization, and how state and federal law interact. For consumers curious about how this affects everyday decisions — including workplace drug testing — see our dedicated drug test guide.

Key Developments: A Timeline of Federal Cannabis Reform

Federal cannabis policy has moved in fits and starts. Below is a chronological overview of the most significant legislative, regulatory, and executive milestones shaping where things stand today.

Impact on Consumers: What Federal Prohibition Means for You

For the tens of millions of Americans who use cannabis legally under their state's laws, federal prohibition creates a surprising number of real-world complications. Understanding these is essential for any informed consumer.

Interstate travel: Carrying cannabis across state lines — even between two legal states — is a federal offense. This applies to air travel as well. TSA agents operate under federal law, and while the agency says it is not specifically searching for cannabis, any discovered marijuana can be referred to law enforcement. Consumers who travel frequently should review our legal explainers before packing.

Drug testing: Federal employees and contractors are subject to strict federal drug-free workplace policies regardless of what state they live in. Even in states with full adult-use programs, federal workers can face termination for a positive THC test. Private employers in legal states have varying policies. For a complete breakdown of how cannabis drug testing works and how long THC stays in your system, see our drug test guide.

Housing and federal benefits: Residents of federally subsidized housing — including Section 8 and public housing — are prohibited from using cannabis regardless of state law. Cannabis use can also affect eligibility for certain federal assistance programs. Veterans seeking VA benefits face similar restrictions.

Banking and consumer protections: Because cannabis is federally illegal, many banks refuse to serve cannabis businesses. This means dispensaries often operate as cash-only, which raises safety and consumer protection concerns. Consumers may have limited recourse if a transaction goes wrong. The pending SAFER Banking Act would help address this, but it has yet to become law.

Medical research and product quality: Federal restrictions have severely limited cannabis research, which means consumers often lack access to the rigorous clinical data available for other medications. Organizations like the FDA have not approved most cannabis products for therapeutic use. Our medical cannabis section explores what research does exist and what it means for patients.

Industry Perspective: Stakes for the Cannabis Business Ecosystem

The US cannabis industry has grown into a multi-billion-dollar sector despite — and in some ways because of — federal prohibition. Entrepreneurs, investors, and operators have built sophisticated businesses within a framework where their product is simultaneously legal under state law and illegal under federal law. That paradox has real consequences.

The most acute pain point is banking access. Under Section 280E of the Internal Revenue Code, cannabis businesses cannot deduct ordinary business expenses because they are trafficking a Schedule I substance. This creates effective tax rates that can exceed 70% — a crushing burden that does not apply to any other legal industry. Rescheduling to Schedule III would eliminate the 280E burden, instantly improving profitability across the sector.

Interstate commerce is another massive constraint. Currently, cannabis cultivated in California cannot legally be sold in Nevada, even though both states have legal markets. This prevents economies of scale and keeps prices artificially high for consumers in smaller markets. True federal legalization would allow interstate commerce, potentially transforming the supply chain and significantly reducing consumer costs.

Publicly traded cannabis companies — particularly multi-state operators (MSOs) — have seen their stock prices react sharply to every development in the federal reform conversation. The prospect of rescheduling sent cannabis stocks surging…